Drug safety reform at the FDA--pendulum swing or systematic improvement?
McClellan
Mark
M
AEI-Brookings Joint Center for Regulatory Studies, Washington, DC, USA.
D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D011307:Drug Prescriptions; D005249:Fees and Charges; D033161:Government Regulation; D018166:Health Care Reform / Q000331:legislation & jurisprudence; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000331:legislation & jurisprudence* / Q000458:organization & administration